SEC Filing Details
Document Details
Form
Filing Date
Oct 30, 2023
Document Date
Oct 18, 2023
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Eiger BioPharmaceuticals
Issuer
EIGER BIOPHARMACEUTICALS, INC.
Filer
KAWAS LEEN